Atrás
37
Rango del Día
$41.88
$43.25
Rango de 52 Semanas
$34.89
$50.88
Volumen
3,917,678
Promedio 50D / 200D
$44.71
/
$44.03
Cierre Anterior
$42.73
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 29.8 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | 8.5 | 3.7 |
| Net Margin % | 4.1 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 1.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$48.59
+14.4%
Low: $38.00
High: $56.00
P/E Futuro
28.9
EPS Futuro
$1.47
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
31 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$2.39
$2.37 – $2.41
|
41 B | 3 |
| FY2029 |
$2.12
$2.10 – $2.14
|
38 B | 3 |
| FY2028 |
$1.85
$1.75 – $2.08
|
36 B | 9 |
Puntos Clave
Generating 1.74B in free cash flow
Cash machine — converts 150.47% of earnings into free cash flow
Capital efficient — spends only 0.00% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)11.47%
Earnings (1Y)-3.42%
FCF Growth (3Y)11.61%
Calidad
Return on Equity
8.50%
ROIC7.12%
Net Margin4.08%
Op. Margin7.78%
Seguridad
Debt / Equity
1.17
Current Ratio4.29
Interest Coverage0.00
Valoración
P/E Ratio
29.75
P/B Ratio3.21
EV/EBITDA20.39
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.47% | Revenue Growth (3Y) | 10.63% |
| Earnings Growth (1Y) | -3.42% | Earnings Growth (3Y) | 122.55% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 28.43B | Net Income (TTM) | 1.16B |
| ROE | 8.50% | ROA | 3.01% |
| Gross Margin | 26.44% | Operating Margin | 7.78% |
| Net Margin | 4.08% | Free Cash Flow (TTM) | 1.74B |
| ROIC | 7.12% | FCF Growth (3Y) | 11.61% |
| Safety | |||
| Debt / Equity | 1.17 | Current Ratio | 4.29 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 29.75 | P/B Ratio | 3.21 |
| P/S Ratio | 1.21 | PEG Ratio | -4.97 |
| EV/EBITDA | 20.39 | Dividend Yield | 0.00% |
| Market Cap | 34.48B | Enterprise Value | 45.10B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 28.43B | 25.51B | 23.23B | 21.45B |
| Net Income | 1.16B | 1.20B | 234.00M | -25.00M |
| EPS (Diluted) | 1.43 | 1.52 | 0.30 | -0.03 |
| Gross Profit | 7.52B | 6.29B | 5.22B | 4.56B |
| Operating Income | 2.21B | 2.23B | 1.44B | 870.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 38.48B | 35.98B | 36.12B |
| Total Liabilities | 19.20B | 19.45B | 19.15B |
| Shareholders' Equity | 10.74B | 16.52B | 16.98B |
| Total Debt | 12.56B | 16.90B | 16.83B |
| Cash & Equivalents | 1.94B | 250.00M | 1.59B |
| Current Assets | 10.68B | 8.27B | 8.81B |
| Current Liabilities | 2.49B | 2.44B | 2.13B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#689 of 1024
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026